Imunon, Inc. Cash and Restricted Cash
Imunon, Inc. (IMNN) had Cash and Restricted Cash of $5.84 million as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-03-28
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.84M.
- 2023-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.88M.
- 2023-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.61M.
- 2023-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16.40M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2023-12-31 | $5.84M 10-K · filed 2024-03-28 |
| 2023-09-30 | $12.88M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $6.61M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $16.40M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $17.49M 10-K · filed 2024-03-28 |
| 2022-09-30 | $32.94M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $32.74M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $34.36M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $25.59M 10-K · filed 2023-03-30 |
| 2021-09-30 | $31.65M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $32.44M 10-Q · filed 2022-08-15 |
| 2020-09-30 | $18.34M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $22.65M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |